Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis
John J. Lepore, Patricia A. Mericko, Lan Cheng, Min Min Lu, Edward E. Morrisey, Michael S. Parmacek
John J. Lepore, Patricia A. Mericko, Lan Cheng, Min Min Lu, Edward E. Morrisey, Michael S. Parmacek
View: Text | PDF
Research Article Cardiology

GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis

  • Text
  • PDF
Abstract

GATA transcription factors play critical roles in restricting cell lineage differentiation during development. Here, we show that conditional inactivation of GATA-6 in VSMCs results in perinatal mortality from a spectrum of cardiovascular defects, including interrupted aortic arch and persistent truncus arteriosus. Inactivation of GATA-6 in neural crest recapitulates these abnormalities, demonstrating a cell-autonomous requirement for GATA-6 in neural crest–derived SMCs. Surprisingly, the observed defects do not result from impaired SMC differentiation but rather are associated with severely attenuated expression of semaphorin 3C, a signaling molecule critical for both neuronal and vascular patterning. Thus, the primary function of GATA-6 during cardiovascular development is to regulate morphogenetic patterning of the cardiac outflow tract and aortic arch. These findings provide new insights into the conserved functions of the GATA-4, -5, and -6 subfamily members and identify GATA-6 and GATA-6–regulated genes as candidates involved in the pathogenesis of congenital heart disease.

Authors

John J. Lepore, Patricia A. Mericko, Lan Cheng, Min Min Lu, Edward E. Morrisey, Michael S. Parmacek

×

Figure 1

Conditional targeting of murine GATA-6.

Options: View larger image (or click on image) Download as PowerPoint
Conditional targeting of murine GATA-6.
(A, top panel) GATA-6 locus cont...
(A, top panel) GATA-6 locus containing exons 3 and 4 (rectangles) and the targeting construct containing phosphoglycerate kinase–regulated (PGK-regulated) neo and HSV thymidine kinase (tk) genes. loxP sites (triangles) flank neo and exon 4 encoding the C-terminal zinc finger (Zn) DNA-binding domain. B, BamHI. (Middle panel) Conditionally targeted GATA-6 allele. (Bottom panel) Targeted allele following selective neo deletion. (B, left) Southern blotting (probe A) of targeted ES cells identifies wild-type (11.1 kb) and conditionally targeted (6.8 kb) alleles. (Right) Southern blotting (probe B) of ES cells following Cre transfection identifies wild-type (11.1 kb) and conditionally targeted alleles with neo (6.2 kb) and with selective neo deletion (4.3 kb). (C) Genotyping of wild-type (+/+), heterozygous (+/F), and homozygous (F/F) conditionally targeted mice. (Left) Southern blotting (probe B) identifies wild-type (11.1 kb) and conditionally targeted (4.3 kb) alleles. (Right) PCR using primers PCR-A and PCR-B identifies products corresponding to wild-type (150 bp) and targeted (110 bp) alleles. (D) Analysis of primary GATA-6F/F aortic SMCs infected with Ad-empty or Ad-Cre. RT-PCR identifies products corresponding to wild-type GATA-6 (373 bp) and GATA-6 following exon 4 deletion (285 bp). Western blotting (WB) identifies full-length (45 kDa) and truncated (41 kDa) GATA-6 proteins. (E) Activation of the GATA-dependent Dab2-LUC reporter. NIH3T3 cells were transiently transfected with 100 ng of the Dab2-LUC reporter and with 0.1–2.0 μg of either pcDNA3–GATA-6 or pcDNA3–GATA-6–Δexon4. The reporter was activated by expression of increasing amounts of wild-type GATA-6, but not by expression of the truncatedATA-6–Δexon4 protein.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts